Michael Valenzuela
Overview
Explore the profile of Michael Valenzuela including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
2799
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sriskandaraja K, Ahmed B, Valenzuela M
Annu Int Conf IEEE Eng Med Biol Soc
. 2020 Oct;
2020:2540-2543.
PMID: 33018524
Clinical and biological changes during the prodromal stages of dementia are both complicated and expensive. A biomarker for cognitive reserve exposure would be highly useful as a dementia risk predictor,...
12.
Abey A, Davies D, Goldsbury C, Buckland M, Valenzuela M, Duncan T
Brain Pathol
. 2020 Aug;
31(1):144-162.
PMID: 32810333
Some aged community dogs acquire a degenerative syndrome termed Canine Cognitive Dysfunction (CCD) that resembles human dementia because of Alzheimer's Disease (AD), with comparable cognitive and behavioral deficits. Dogs also...
13.
Ooi L, Dottori M, Cook A, Engel M, Gautam V, Grubman A, et al.
Neuroscientist
. 2020 Apr;
26(5-6):438-454.
PMID: 32281909
Because our beliefs regarding our individuality, autonomy, and personhood are intimately bound up with our brains, there is a public fascination with cerebral organoids, the "mini-brain," the "brain in a...
14.
Ginige J, Boulamatsis C, Heffernan M, San Jose J, Chuprov I, Chau T, et al.
Stud Health Technol Inform
. 2020 Mar;
268:97-112.
PMID: 32141882
Maintain Your Brain (MYB)i is a randomised controlled trial (RCT) of multiple online interventions designed to target modifiable risk factors for Alzheimer's disease and dementia. Traditional clinical trial management systems...
15.
Walton C, Lampit A, Boulamatsis C, Hallock H, Barr P, Ginige J, et al.
JMIR Aging
. 2019 Sep;
2(1):e13135.
PMID: 31518277
Background: Dementia is the leading cause of disability worldwide, and interventions aimed at reducing the prevalence and burden of the disease are urgently needed. Maintain Your Brain (MYB) is a...
16.
Sturnieks D, Menant J, Valenzuela M, Delbaere K, Sherrington C, Herbert R, et al.
BMJ Open
. 2019 Aug;
9(8):e029409.
PMID: 31377709
Background: Physical and cognitive impairments are important risk factors for falls in older people. However, no studies have been adequately powered to examine whether cognitive or cognitive-motor training can prevent...
17.
Lampit A, Heine J, Finke C, Barnett M, Valenzuela M, Wolf A, et al.
Neurorehabil Neural Repair
. 2019 Jul;
33(9):695-706.
PMID: 31328637
. Cognitive impairments are common in people with multiple sclerosis (MS). Systematic reviews reported promising evidence for various cognitive interventions in this population. Computerized cognitive training (CCT) has strong evidence...
18.
Stern Y, Chetelat G, Habeck C, Arenaza-Urquijo E, Vemuri P, Estanga A, et al.
Nat Rev Neurosci
. 2019 Mar;
20(4):246.
PMID: 30814677
No abstract available.
19.
Kua Z, Valenzuela M, Dong Y
J Cardiovasc Nurs
. 2018 Dec;
34(2):E19-E27.
PMID: 30585868
Background: Cognitive impairment is highly prevalent in patients with heart failure (HF), negatively impacting self-care and consequently increasing mortality. Although computerized cognitive training (CCT) has been found to be efficacious...
20.
Heffernan M, Andrews G, Fiatarone Singh M, Valenzuela M, Anstey K, Maeder A, et al.
J Alzheimers Dis
. 2018 Nov;
70(s1):S221-S237.
PMID: 30475762
Background: Maintain Your Brain (MYB) is a randomized controlled trial of an online multi-modal lifestyle intervention targeting modifiable dementia risk factors with its primary aim being to reduce cognitive decline...